Drug Type Small molecule drug |
Synonyms Compound 18(Daiichi Sankyo, Inc.) |
Target |
Action stimulants |
Mechanism Hemoglobins stimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H19N3O3 |
InChIKeyIUWTWZMRWOKWGL-UHFFFAOYSA-N |
CAS Registry2987004-95-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anemia, Sickle Cell | Preclinical | United States | 01 Oct 2020 | |
| Beta-Thalassemia | Preclinical | United States | 01 Oct 2020 |





